| pubmed-article:20950790 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20950790 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:20950790 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:20950790 | lifeskim:mentions | umls-concept:C0080276 | lld:lifeskim |
| pubmed-article:20950790 | lifeskim:mentions | umls-concept:C0279025 | lld:lifeskim |
| pubmed-article:20950790 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:20950790 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20950790 | pubmed:dateCreated | 2010-12-28 | lld:pubmed |
| pubmed-article:20950790 | pubmed:abstractText | To investigate the prevalence of urogenital symptoms and vaginal atrophy in postmenopausal breast cancer patients on adjuvant endocrine therapy. | lld:pubmed |
| pubmed-article:20950790 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20950790 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20950790 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20950790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20950790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20950790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20950790 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20950790 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:20950790 | pubmed:issn | 1097-6868 | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:VillmanKennet... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:Stavreus-Ever... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:LindmanHenrik... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:NilssonKersti... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:Sundström-Por... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:KaskKristiina... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:BaumgartJulia... | lld:pubmed |
| pubmed-article:20950790 | pubmed:author | pubmed-author:KallakTheodor... | lld:pubmed |
| pubmed-article:20950790 | pubmed:copyrightInfo | Copyright © 2011 Mosby, Inc. All rights reserved. | lld:pubmed |
| pubmed-article:20950790 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20950790 | pubmed:volume | 204 | lld:pubmed |
| pubmed-article:20950790 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20950790 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20950790 | pubmed:pagination | 26.e1-7 | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:meshHeading | pubmed-meshheading:20950790... | lld:pubmed |
| pubmed-article:20950790 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20950790 | pubmed:articleTitle | Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. | lld:pubmed |
| pubmed-article:20950790 | pubmed:affiliation | Department of Obstetrics and Gynecology, Örebro University Hospital, Sweden. | lld:pubmed |
| pubmed-article:20950790 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20950790 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
